Literature DB >> 11447192

Differences in levels of secreted locus of enterocyte effacement proteins between human disease-associated and bovine Escherichia coli O157.

A McNally1, A J Roe, S Simpson, F M Thomson-Carter, D E Hoey, C Currie, T Chakraborty, D G Smith, D L Gally.   

Abstract

Ongoing extensive epidemiological studies of verotoxin-carrying Escherichia coli O157 (stx(+) eae(+)) have shown this bacterial pathogen to be common in cattle herds in the United States and the United Kingdom. However, the incidence of disease in humans due to this pathogen is still very low. This study set out to investigate if there is a difference between strains isolated from human disease cases and those isolated from asymptomatic cattle which would account for the low disease incidence of such a ubiquitous organism. The work presented here has compared human disease strains from both sporadic and outbreak cases with a cross-section, as defined by pulsed-field gel electrophoresis, of E. coli O157 strains from cattle. Human (n = 22) and bovine (n = 31) strains were genotyped for carriage of the genes for Shiga-like toxin types 1, 2, and 2c; E. coli secreted protein genes espA, espB, and espP; the enterohemolysin gene; eae (intimin); ast (enteroaggregative E. coli stable toxin [EAST]); and genes for common E. coli adhesins. Strains were also phenotyped for hemolysin, EspP, Tir, and EspD expression as well as production of actin and cytoskeletal rearrangement associated with attaching and effacing (A/E) lesions on HeLa cells. The genotyping confirmed that there was little difference between the two groups, including carriage of stx(2) and stx(2c), which was similar in both sets. ast alleles were confirmed to all contain mutations that would prevent EAST expression. espP mutations were found only in cattle strains (5 of 30). Clear differences were observed in the expression of locus of enterocyte effacement (LEE)-encoded factors between strains and in different media. EspD, as an indicator of LEE4 (espA, -B, and -D) expression, and Tir levels in supernatants were measured. Virtually all strains from both sources could produce EspD in Luria-Bertani broth, although at very different levels. Standard trichloroacetic acid precipitation of secreted proteins from tissue culture medium produced detectable levels of EspD from the majority of strains of human origin (15 of 20) compared with only a few (4 of 20) bovine strains (P < 0.001), which is indicative of much higher levels of protein secretion from the human strains. Addition of bovine serum albumin carrier protein before precipitation and enhanced detection techniques confirmed that EspD could be detected after growth in tissue culture medium for all strains, but levels from strains of human origin were on average 90-fold higher than those from strains of bovine origin. In general, levels of secretion also correlated with ability to form A/E lesions on HeLa cells, with only the high-level protein secretors in tissue culture medium exhibiting a localized adherence phenotype. This research shows significant differences between human- and bovine-derived E. coli O157 (stx(+) eae(+)) strains and their production of certain LEE-encoded virulence factors. These data support the recent finding of Kim et al. (J. Kim, J. Nietfeldt, and A. K. Benson, Proc. Natl. Acad. Sci. USA 96:13288-13293, 1999) proposing different E. coli O157 lineages in cattle and humans and extend the differential to the regulation of virulence factors. Potentially only a subset of E. coli O157 isolates (stx(+) eae(+)) in cattle may be capable of causing severe disease in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447192      PMCID: PMC98606          DOI: 10.1128/IAI.69.8.5107-5114.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation.

Authors:  K Al-Hasani; I R Henderson; H Sakellaris; K Rajakumar; T Grant; J P Nataro; R Robins-Browne; B Adler
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Characterization of a recurrent clonal type of Escherichia coli O157:H7 causing major outbreaks of infection in Scotland.

Authors:  L J Allison; P E Carter; F M Thomson-Carter
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

3.  Analysis of type 1 fimbriae expression in verotoxigenic Escherichia coli: a comparison between serotypes O157 and O26.

Authors:  A J Roe; C Currie; D G Smith; D L Gally
Journal:  Microbiology       Date:  2001-01       Impact factor: 2.777

4.  Comparison of the nucleotide sequence of enteroaggregative Escherichia coli heat-stable enterotoxin 1 genes among diarrhea-associated Escherichia coli.

Authors:  T Yamamoto; N Wakisaka; F Sato; A Kato
Journal:  FEMS Microbiol Lett       Date:  1997-02-01       Impact factor: 2.742

Review 5.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements.

Authors:  Werner Brunder; Herbert Schmidt; Matthias Frosch; Helge Karch
Journal:  Microbiology       Date:  1999-05       Impact factor: 2.777

7.  The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S J Elliott; V Sperandio; J A Girón; S Shin; J L Mellies; L Wainwright; S W Hutcheson; T K McDaniel; J B Kaper
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

8.  Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.

Authors:  P Boerlin; S A McEwen; F Boerlin-Petzold; J B Wilson; R P Johnson; C L Gyles
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Prevalence and characteristics of human and bovine verotoxigenic Escherichia coli strains isolated in Galicia (north-western Spain).

Authors:  M Blanco; J E Blanco; J Blanco; E A Gonzalez; M P Alonso; H Maas; W H Jansen
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

10.  Detection of the enteroaggregative Escherichia coli heat-stable enterotoxin 1 gene sequences in enterotoxigenic E. coli strains pathogenic for humans.

Authors:  T Yamamoto; P Echeverria
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

View more
  24 in total

1.  Genome signatures of Escherichia coli O157:H7 isolates from the bovine host reservoir.

Authors:  Mark Eppinger; Mark K Mammel; Joseph E Leclerc; Jacques Ravel; Thomas A Cebula
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

2.  Serotypes and virulence profiles of non-O157 Shiga toxin-producing Escherichia coli isolates from bovine farms.

Authors:  Aine Monaghan; Brian Byrne; Séamus Fanning; Torres Sweeney; David McDowell; Declan J Bolton
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

3.  Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection.

Authors:  Manohar John; Indira T Kudva; Robert W Griffin; Allen W Dodson; Bethany McManus; Bryan Krastins; David Sarracino; Ann Progulske-Fox; Jeffrey D Hillman; Martin Handfield; Phillip I Tarr; Stephen B Calderwood
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Retracted science and the retraction index.

Authors:  Ferric C Fang; Arturo Casadevall
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

5.  stx1c Is the most common Shiga toxin 1 subtype among Shiga toxin-producing Escherichia coli isolates from sheep but not among isolates from cattle.

Authors:  Kim N Brett; Vidiya Ramachandran; Michael A Hornitzky; Karl A Bettelheim; Mark J Walker; Steven P Djordjevic
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

6.  Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.

Authors:  Jenny M Ritchie; Patrick L Wagner; David W K Acheson; Matthew K Waldor
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

7.  Serotypes and virulence gene profiles of shiga toxin-producing Escherichia coli strains isolated from feces of pasture-fed and lot-fed sheep.

Authors:  Steven P Djordjevic; Vidiya Ramachandran; Karl A Bettelheim; Barbara A Vanselow; Peter Holst; Graham Bailey; Michael A Hornitzky
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

8.  Heterogeneous surface expression of EspA translocon filaments by Escherichia coli O157:H7 is controlled at the posttranscriptional level.

Authors:  Andrew J Roe; Helen Yull; Stuart W Naylor; Martin J Woodward; David G E Smith; David L Gally
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications.

Authors:  Nurmohammad Shaikh; Phillip I Tarr
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

10.  Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.

Authors:  Diane R Baker; Rodney A Moxley; Mike B Steele; Jeffrey T Lejeune; Jane Christopher-Hennings; Ding-Geng Chen; Philip R Hardwidge; David H Francis
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.